475 related articles for article (PubMed ID: 9858514)
1. Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses.
Ermak TH; Giannasca PJ; Nichols R; Myers GA; Nedrud J; Weltzin R; Lee CK; Kleanthous H; Monath TP
J Exp Med; 1998 Dec; 188(12):2277-88. PubMed ID: 9858514
[TBL] [Abstract][Full Text] [Related]
2. Helicobacter pylori infection in immunized mice lacking major histocompatibility complex class I and class II functions.
Pappo J; Torrey D; Castriotta L; Savinainen A; Kabok Z; Ibraghimov A
Infect Immun; 1999 Jan; 67(1):337-41. PubMed ID: 9864234
[TBL] [Abstract][Full Text] [Related]
3. Parenteral adjuvant activities of Escherichia coli heat-labile toxin and its B subunit for immunization of mice against gastric Helicobacter pylori infection.
Weltzin R; Guy B; Thomas WD; Giannasca PJ; Monath TP
Infect Immun; 2000 May; 68(5):2775-82. PubMed ID: 10768972
[TBL] [Abstract][Full Text] [Related]
4. Mucosal immunization with a urease B DNA vaccine induces innate and cellular immune responses against Helicobacter pylori.
Hatzifoti C; Roussel Y; Harris AG; Wren BW; Morrow JW; Bajaj-Elliott M
Helicobacter; 2006 Apr; 11(2):113-22. PubMed ID: 16579841
[TBL] [Abstract][Full Text] [Related]
5. Oral Immunization with a Multivalent Epitope-Based Vaccine, Based on NAP, Urease, HSP60, and HpaA, Provides Therapeutic Effect on
Guo L; Yang H; Tang F; Yin R; Liu H; Gong X; Wei J; Zhang Y; Xu G; Liu K
Front Cell Infect Microbiol; 2017; 7():349. PubMed ID: 28824883
[TBL] [Abstract][Full Text] [Related]
6. The C-terminally encoded, MHC class II-restricted T cell antigenicity of the Helicobacter pylori virulence factor CagA promotes gastric preneoplasia.
Arnold IC; Hitzler I; Engler D; Oertli M; Agger EM; Müller A
J Immunol; 2011 Jun; 186(11):6165-72. PubMed ID: 21518972
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic Protection Against
Guo L; Hong D; Wang S; Zhang F; Tang F; Wu T; Chu Y; Liu H; He M; Yang H; Yin R; Liu K
Front Immunol; 2019; 10():1185. PubMed ID: 31191547
[TBL] [Abstract][Full Text] [Related]
8. Rectal and intranasal immunizations with recombinant urease induce distinct local and serum immune responses in mice and protect against Helicobacter pylori infection.
Kleanthous H; Myers GA; Georgakopoulos KM; Tibbitts TJ; Ingrassia JW; Gray HL; Ding R; Zhang ZZ; Lei W; Nichols R; Lee CK; Ermak TH; Monath TP
Infect Immun; 1998 Jun; 66(6):2879-86. PubMed ID: 9596763
[TBL] [Abstract][Full Text] [Related]
9. Protection against Helicobacter pylori infection in BALB/c mice by oral administration of multi-epitope vaccine of CTB-UreI-UreB.
Yang J; Dai LX; Pan X; Wang H; Li B; Zhu J; Li MY; Shi XL; Wang BN
Pathog Dis; 2015 Jul; 73(5):. PubMed ID: 25846576
[TBL] [Abstract][Full Text] [Related]
10. Oral immunization with recombinant Helicobacter pylori urease induces secretory IgA antibodies and protects mice from challenge with Helicobacter felis.
Lee CK; Weltzin R; Thomas WD; Kleanthous H; Ermak TH; Soman G; Hill JE; Ackerman SK; Monath TP
J Infect Dis; 1995 Jul; 172(1):161-72. PubMed ID: 7797906
[TBL] [Abstract][Full Text] [Related]
11. Oral immunization with recombinant Helicobacter pylori urease confers long-lasting immunity against Helicobacter felis infection.
Myers GA; Ermak TH; Georgakopoulos K; Tibbitts T; Ingrassia J; Gray H; Kleanthous H; Lee CK; Monath TP
Vaccine; 1999 Mar; 17(11-12):1394-403. PubMed ID: 10195775
[TBL] [Abstract][Full Text] [Related]
12. Development and evaluation of a DNA vaccine based on Helicobacter pylori urease B: failure to prevent experimental infection in the mouse model.
Zavala-Spinetti L; Breslin MB; Correa H; Bégué RE
Helicobacter; 2006 Dec; 11(6):517-22. PubMed ID: 17083372
[TBL] [Abstract][Full Text] [Related]
13. Intranasal CpG-oligodeoxynucleotide is a potent adjuvant of vaccine against Helicobacter pylori, and T helper 1 type response and interferon-gamma correlate with the protection.
Shi T; Liu WZ; Gao F; Shi GY; Xiao SD
Helicobacter; 2005 Feb; 10(1):71-9. PubMed ID: 15691317
[TBL] [Abstract][Full Text] [Related]
14. Effects of vaccination by a recombinant antigen ureB138 (a segment of the beta-subunit of urease) against Helicobacter pylori infection.
Morihara F; Fujii R; Hifumi E; Nishizono A; Uda T
J Med Microbiol; 2007 Jun; 56(Pt 6):847-853. PubMed ID: 17510273
[TBL] [Abstract][Full Text] [Related]
15. Protection of mice against gastric colonization by Helicobacter pylori by single oral dose immunization with attenuated Salmonella typhimurium producing urease subunits A and B.
Gómez-Duarte OG; Lucas B; Yan ZX; Panthel K; Haas R; Meyer TF
Vaccine; 1998 Mar; 16(5):460-71. PubMed ID: 9491500
[TBL] [Abstract][Full Text] [Related]
16. Immunization of rhesus monkeys with a mucosal prime, parenteral boost strategy protects against infection with Helicobacter pylori.
Lee CK; Soike K; Giannasca P; Hill J; Weltzin R; Kleanthous H; Blanchard J; Monath TP
Vaccine; 1999 Aug; 17(23-24):3072-82. PubMed ID: 10462242
[TBL] [Abstract][Full Text] [Related]
17. Attenuated Salmonella enterica serovar Typhi expressing urease effectively immunizes mice against Helicobacter pylori challenge as part of a heterologous mucosal priming-parenteral boosting vaccination regimen.
Londoño-Arcila P; Freeman D; Kleanthous H; O'Dowd AM; Lewis S; Turner AK; Rees EL; Tibbitts TJ; Greenwood J; Monath TP; Darsley MJ
Infect Immun; 2002 Sep; 70(9):5096-106. PubMed ID: 12183559
[TBL] [Abstract][Full Text] [Related]
18. Immunological features and efficacy of the reconstructed epitope vaccine CtUBE against Helicobacter pylori infection in BALB/c mice model.
Guo L; Liu K; Zhao W; Li X; Li T; Tang F; Zhang R; Wu W; Xi T
Appl Microbiol Biotechnol; 2013 Mar; 97(6):2367-78. PubMed ID: 23064457
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity characterization of the multi-epitope vaccine CTB-UE with chitosan-CpG as combination adjuvants against Helicobacter pylori.
Xing Y; Liu W; Li X; Guo L; Lv X; Xi T
Biochem Biophys Res Commun; 2015 Jul; 462(3):269-74. PubMed ID: 25957472
[TBL] [Abstract][Full Text] [Related]
20. The nontoxic CTA1-DD adjuvant enhances protective immunity against Helicobacter pylori infection following mucosal immunization.
Akhiani AA; Stensson A; Schön K; Lycke N
Scand J Immunol; 2006 Feb; 63(2):97-105. PubMed ID: 16476008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
